EMA Seeks Comments on New Stakeholder Platform for Improving Trials

March 1, 2023

The EMA is requesting public comment on its new multi-stakeholder platform, Accelerating Clinical Trials (ACT) EU, for improving clinical trials within the trade bloc.

25Apr
Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials
26Apr
FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know
27Apr
Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis
17May
2023 WCG Avoca Quality Consortium Summit
21May
WCG MAGI Clinical Research Conference – 2023 East

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here

EMA Seeks Comments on New Stakeholder Platform for Improving Trials

Upcoming Events

Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

2023 WCG Avoca Quality Consortium Summit

WCG MAGI Clinical Research Conference – 2023 East

Featured Products

Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

Consider the Five ‘W’s to Understand Potential Participants

Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

Trial Stakeholders Advise White House on Emergency Research Infrastructure

Stress Levels Continue to Climb in Healthcare Workforce, Survey Finds

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.